These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 26287244

  • 1. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
    Cote CK, Welkos SL.
    Toxins (Basel); 2015 Aug 17; 7(8):3167-78. PubMed ID: 26287244
    [Abstract] [Full Text] [Related]

  • 2. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 Aug 17; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 3. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D, Bartoszcze M, Niemcewicz M, Bielawska-Drózd A, Kocik J.
    Ann Agric Environ Med; 2012 Aug 17; 19(4):613-8. PubMed ID: 23311776
    [Abstract] [Full Text] [Related]

  • 4. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin.
    Majumder S, Das S, Somani VK, Makam SS, Kingston JJ, Bhatnagar R.
    Front Immunol; 2019 Aug 17; 10():498. PubMed ID: 30941133
    [Abstract] [Full Text] [Related]

  • 5. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S, Das S, Somani V, Makam SS, Joseph KJ, Bhatnagar R.
    Sci Rep; 2018 May 08; 8(1):7242. PubMed ID: 29740033
    [Abstract] [Full Text] [Related]

  • 6. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W.
    BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192
    [Abstract] [Full Text] [Related]

  • 7. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
    Banks DJ, Barnajian M, Maldonado-Arocho FJ, Sanchez AM, Bradley KA.
    Cell Microbiol; 2005 Aug 12; 7(8):1173-85. PubMed ID: 16008584
    [Abstract] [Full Text] [Related]

  • 8. Fate of germinated Bacillus anthracis spores in primary murine macrophages.
    Guidi-Rontani C, Levy M, Ohayon H, Mock M.
    Mol Microbiol; 2001 Nov 12; 42(4):931-8. PubMed ID: 11737637
    [Abstract] [Full Text] [Related]

  • 9. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.
    Booth JL, Duggan ES, Patel VI, Langer M, Wu W, Braun A, Coggeshall KM, Metcalf JP.
    Microbes Infect; 2016 Oct 12; 18(10):615-626. PubMed ID: 27320392
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J, Cho M, Lee HR, Cha K, Chun JH, Hong KJ, Park J, Rhie GE.
    Biochim Biophys Acta; 2013 Mar 12; 1830(3):2804-12. PubMed ID: 23201204
    [Abstract] [Full Text] [Related]

  • 11. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.
    Cote CK, DiMezzo TL, Banks DJ, France B, Bradley KA, Welkos SL.
    Microbes Infect; 2008 May 12; 10(6):613-9. PubMed ID: 18467145
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 14. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
    Welkos S, Friedlander A, Weeks S, Little S, Mendelson I.
    J Med Microbiol; 2002 Oct 01; 51(10):821-831. PubMed ID: 12435060
    [Abstract] [Full Text] [Related]

  • 15. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J.
    Infect Immun; 2007 Jul 01; 75(7):3414-24. PubMed ID: 17452469
    [Abstract] [Full Text] [Related]

  • 16. Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.
    Sinha K, Bhatnagar R.
    Med Microbiol Immunol; 2013 Apr 01; 202(2):153-65. PubMed ID: 23263010
    [Abstract] [Full Text] [Related]

  • 17. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.
    Int J Med Microbiol; 2004 Jul 01; 294(1):35-44. PubMed ID: 15293452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Macrophage interactions.
    Guidi-Rontani C, Mock M.
    Curr Top Microbiol Immunol; 2002 Jul 01; 271():115-41. PubMed ID: 12224520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.